From the *Ministry of Health, Khartoum, Sudan; †World Health Organization, Regional Office for the Eastern Mediterranean, Cairo, Egypt; and ‡Centers for Diseases Control and Prevention, Atlanta, GA.
Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S23-7. doi: 10.1097/INF.0000000000000095.
In 2011, Sudan became the first low-income country in Africa to introduce a rotavirus vaccine. Prevaccine baseline data on rotavirus disease burden are crucial for monitoring the impact of this new vaccine program.
We conducted active, hospital-based surveillance for rotavirus disease at 8 regional public hospitals in Sudan using a standard protocol recommended by the World Health Organization for 2 full years immediately preceding vaccine introduction. Cases were children <5 years hospitalized with gastroenteritis, defined as acute onset of 3 or more loose stools or 2 or more episodes of vomiting in a 24-hour period. Stool specimens from cases were tested for rotavirus using a commercially available assay.
From June 2009 to May 2011, rotavirus was detected in 3985 (36%) of 10,953 children hospitalized for gastroenteritis, with detection rates ranging from 25% to 48% at the 8 hospitals. Approximately 61% of the rotavirus hospitalizations occurred before 1 year of age and most (91%) occurred before 2 years of age. Rotavirus was detected year-round in Sudan with peaks during March to May and November to December. Applying rotavirus prevalence to national estimates of diarrhea events, we calculated 9800 deaths, 22,800 hospitalizations and 55,400 outpatient visits related to rotavirus per year among children <5 years of age in Sudan.
The high burden of rotavirus disease in Sudan indicates that the recently implemented vaccination program should substantially improve child health in Sudan. This nationwide rotavirus surveillance system will be an important platform for assessing the benefits and value of rotavirus vaccine in a developing country setting.
2011 年,苏丹成为非洲首个引入轮状病毒疫苗的低收入国家。疫苗接种前的基线数据对于监测这种新疫苗计划的效果至关重要。
我们在苏丹 8 家地区公立医院使用世界卫生组织推荐的标准方案,对轮状病毒疾病进行了为期 2 年的主动、基于医院的监测,监测对象为在疫苗接种前 2 年内入院的 5 岁以下患有肠胃炎的儿童。肠胃炎的定义为急性发作,即 24 小时内出现 3 次以上稀便或 2 次以上呕吐。采用市售检测方法检测病例粪便中的轮状病毒。
2009 年 6 月至 2011 年 5 月,3985 例(36%)因肠胃炎入院的儿童粪便中检测到轮状病毒,8 家医院的检测率在 25%至 48%之间。约 61%的轮状病毒住院病例发生在 1 岁之前,其中 91%发生在 2 岁之前。苏丹全年均可检测到轮状病毒,高峰期在 3 月至 5 月和 11 月至 12 月。根据腹泻事件的全国估计数,轮状病毒流行率,我们计算出苏丹每年 5 岁以下儿童有 9800 人死亡、22800 人住院和 55400 人门诊与轮状病毒相关。
苏丹轮状病毒疾病负担高,表明最近实施的疫苗接种计划应能显著改善苏丹儿童的健康。该全国性轮状病毒监测系统将成为评估发展中国家轮状病毒疫苗效益和价值的重要平台。